Circadian rhythm of cellular proliferation in the human rectal mucosa

Scheving, 1972, Circadian rhythms in mitotic activity and 3H-thymidine uptake in the duodenum: effect of isoproterenol on the mitotic index, Am J Anat, 135, 311, 10.1002/aja.1001350302 Scheving, 1978, Circadian variation and cell division of the mouse alimentary tract, bone marrow and corneal epithelium, Anat Rec, 191, 479, 10.1002/ar.1091910407 Rubin, 1982, Influence of the circadian rhythm in cell division on radiation-induced mitotic delay in vivo, Radiat Res, 89, 65, 10.2307/3575685 Burns, 1972, Circadian rhythm in uptake of tritiated thymidine by kidney, parotid and duodenum of isoproterenol-treated mice, Science, 175, 71, 10.1126/science.175.4017.71 Laerum, 1981, Chronobiological aspects of bone marrow and blood cells, 87 Sigdestad, 1969, Diurnal fluctuation in the number of cells in mitosis and DNA synthesis in the jejunum of the mouse, Exp Cell Res, 58, 159, 10.1016/0014-4827(69)90126-8 Scheving, 1983, Chronobiology of the intestinal tract of the mouse, Am J Anat, 168, 433, 10.1002/aja.1001680405 Scheving, 1959, Mitotic activity in the human epidermis, Anat Rec, 135, 7, 10.1002/ar.1091350103 Fisher, 1968, The diurnal mitotic rhythm in the human epidermis, Br J Dermatol, 80, 75, 10.1111/j.1365-2133.1968.tb12263.x Zugula-Mally, 1979, Time point differences in skin mitotic activity of actinic keratoses and skin cancer, 399 Killmann, 1962, Mitotic indices of human bone marrow cells. I. Number and physiologic distribution of mitosis, Blood, 19, 743, 10.1182/blood.V19.6.743.743 Mauer, 1965, Diurnal variation of proliferative activity in the human bone marrow, Blood, 26, 1, 10.1182/blood.V26.1.1.1 Markiewicz, 1983, Circadian rhythms of four marker enzymes activity of the jejunal villi in man, Acta Histochem (Jena), 72, 91, 10.1016/S0065-1281(83)80015-4 Klevecz, 1987, Circadian gating of S phase in human ovarian cancer, Cancer Res, 47, 6267 Scheving, 1980, Circadian bioperiodic response of mice bearing advanced L1210 leukemia by combination therapy with adriamycin and cyclophosphamide, Cancer Res, 40, 1511 Haus, 1972, Increased tolerance of leukemic mice to arabinosyl cytosine with schedule adjusted to circadian system, Science, 177, 80, 10.1126/science.177.4043.80 Hrushesky, 1984, Chemotherapy timing: an important variable in toxicity and response, 449 Hinegardner, 1971, An improved fluorometric assay for DNA, Anal Biochem, 39, 197, 10.1016/0003-2697(71)90476-3 Giro, 1985, Demonstration of elastin gene expression in human skin fibroblast cultures and reduced tropoelastin production by cells with atrophoderma, J Clin Invest, 75, 672, 10.1172/JCI111746 Nelson, 1979, Methods for cosinorrhythmometry, Chronobiologia, 6, 305 Bingham, 1982, Inferential statistical methods for estimating and comparing cosinor parameters, Chronobiologia, 9, 397 Scheving, 1984, Effect of fasting on circadian rhythmicity in deoxyribonucleic acid synthesis of several murine tissues, J Nutr, 114, 2160, 10.1093/jn/114.11.2160 Maurer, 1981, Potential pitfalls of 3H thymidine techniques to measure cell proliferation, Cell Tissue Kinet, 14, 111 Hyrniuk, 1986, Analysis of dose intensity for chemotherapy in early (stage II) and advanced breast cancer, NCI Monograph, 1, 87 Dublin, 1940, Mitosis in specimens removed during day and night from carcinoma of large intestine, Arch Pathol, 30, 893 Scheving, 1977, Can chronobiology be ignored when considering the cancer problem?, Volume 1, 1063 Scheving, 1984, Chronobiology of cell proliferation in mammals: implications for basic research and cancer chemotherapy, 455 Sothern, 1989, Doxorubicin-cisplatin control of a murine plasmacytoma depends upon circadian stage of treatment, J Natl Cancer Inst, 81, 135, 10.1093/jnci/81.2.135 Hrushesky, 1986, Circadian drug schedule affects drug toxicity,ovarian cancer response, and patient survival, 203 Rivard, 1985, Maintenance chemotherapy for childhood acute lymphoblastic leukemia; better in the evening, Lancet, 2, 1264, 10.1016/S0140-6736(85)91551-X Hrushesky, 1985, Circadian timing of cancer chemotherapy, Science, 228, 73, 10.1126/science.3883493 Roemeling, 1987, Circadian pattern of continuous FUDR infusion reduces toxicities, 357 Levi, 1986, Clinical chronopharmacologic optimization of hematologic tolerance for theanticancer agent 4′-O-tetrahydropyranyl adriamycin (TH). Preliminary results, Volume 3, 199 Roemeling, 1988, Randomized toxicity and dose intensity (DI) comparison of constant rate vs. circadian modified continuous FUDR infusion Hrushesky, 1988, Effective, safe outpatient treatment for progressive metastatic renal cell cancer (RCC)